ABSTRACT:
This review aims to cover the literature published methodologies of the total synthesis of the (-)-swainsonine alkaloid natural product that has been reported between the years 2005 and 2020. (-)-Swainsonine has been widely studied for many important biological activities and scientifically reported to possess such as anticancer, antimetastatic, antitumor, antiviral and anti-HIV.
Cite this article:
Rafid S. Dawood. A review on the total synthesis of (-)-Swainsonine natural product(2005-2020). Research J. Pharm. and Tech. 2021; 14(1):531-537. doi: 10.5958/0974-360X.2021.00097.4
Cite(Electronic):
Rafid S. Dawood. A review on the total synthesis of (-)-Swainsonine natural product(2005-2020). Research J. Pharm. and Tech. 2021; 14(1):531-537. doi: 10.5958/0974-360X.2021.00097.4 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-1-97
REFERENCES:
1. Kurgat CC, Kibet JK, Cheplogoi PK, Limo SC, Kimani PM. Asian Journal of Research in Chemistry, 2016; 11, 205.
2. Mumu C. Asian Journal of Research in Chemistry, 2018; 11, 337.
3. Premlata S, Krishan KM, Padma K. Asian Journal of Research in Chemistry, 2018; 11, 432.
4. Muthumani P, Meera R, Devi P, Kameswari B. Research Journal of Pharmacy and Technology, 2010; 3, 736.
5. Dheeraj A, Bharti A, Anish C. Research Journal of Pharmacy and Technology, 2013; 6, 618.
6. Shanaz B, Josephine LJ, Manjula D, Premakumari KB. Research Journal of Pharmacy and Technology, 2020; 13, 163.
7. Fowsiya J, Madhumitha G. Research Journal of Pharmacy and Technology, 2020; 13, 963.
8. Monago CC, Nwodo O, Fred C. Research Journal of Pharmacognosy and Phytochemistry, 2010; 2, 331.
9. Shukla A, Bigoniya P. Research Journal of Pharmacognosy and Phytochemistry, 2013; 5, 94.
10. AL-Khateeb IH. Baghdad Science Journal, 2019, 16, 550-554.
11. Demelo EB, Silveria GA, Carvalho I. Tetrahedron, 2006;62, 10277.
12. Lillelund VH, Jensen HH, Liang XF, Bols M. Chemical Review,2002; 102, 515.
13. Heihtman TD, Vasella AT. Angewandte Chemie International Edition,1999; 38, 750.
14. Asano N, Nash RJ, Molyneux RJ, Fleet GWJ. Tetrahedron Asymmetry,2000;11, 1645.
15. Asano N. Glycobiology,2003, 13, 93R.
16. Watson A, Fleet GWJ, AsanoN, Molyneux RJ, Nash RJ. Phytochemistry,2001;56, 265.
17. Gerber LS, Juillerat JL. Mini-Reviews in Medicinal Chemistry,2006;6, 1043.
18. MichaelJP. Natural Product Reports, 2004; 19, 625.
19. Asano N, Nash RJ, Molyneux RJ, Fleet GWJ. Tetrahedron Asymmetry, 2000; 11,1645.
20. Guengerich FP, Di Mari SJ, Broquist HP. Journal of the American Chemical Society, 1973;95, 2055.
21. Colegate SM, Dorling PR, Huxtable CR. Australian Journal of Chemistry,1979;32, 2257.
22. Marilyn JS, Frank SU, Harry PB, Thomas MH. Tetrahedron, 1983;39,29.
23. Hino M, Nakayama O, Tsurumi Y, Adachi K, Shibata T, Terano H, Kohsaka M, Aoki H, Imanaka H. The Journal of Antibiotics, 1985; 38, 926.
24. Patrick M, Adlard MW, Keshavarz T. Biotechnology Letters, 1993; 15, 997e1000.
25. Molyneux RJ, James LF. Science, Washington, D.C.1982; 216, 190.
26. Davis D, Schwarz P, Hernandez T, Mitchell M, Warnock B, Elbein AD. Plant Physiology, 1984; 76, 972.
27. Elbein AD, Solf R, Dorling PR, Vosbeck K. Proceedings of the National Academy of Sciences, U.S.A., 1981; 78, 7393.
28. Kaushal GP, Szumilo T, Pastuszak I, Elbein AD. Biochemistry, 1990; 29, 2168.
29. Pastuszak I, Kaushal GP, Wall KA, Pan YT, Sturm A, Elbein AD. Glycobiology, 1990; 1, 71.
30. Schneider MJ, Ungemach FS, Broquist HP, Harris TM, Tetrahedron, 1983; 39, 29.
31. Liao YF, Lal A, Moremen KW. The Journal of Biological Chemistry, 1996; 271, 28348.
32. Burgess K, HendersonI. Tetrahedron,1992;48, 4045.
33. Goss PE, Reid CL, Bailey D, Dennis JW. Clinical Cancer Research,1997;3, 11077.
34. Galustian C, Foulds S, Dye JF, Guillou PJ. Immunopharmacology, 1994;27, 165.
35. Granato DA, Neeser JR. Molecular Immunology, 1987; 24, 849.
36. Humphries MJ, Matsumoto K, White SL, Molyneus RJ, Olden K. Cancer Research, 1988; 48, 1410.
37. Elbein AD, Dorling PR, Vosbeck K, Horisberger M. The journal of Biological Chemistry,1982; 257, 1573.
38. Bowen D, Southerland WM, Bowen CD, Hughes DE. Anticancer Research, 1997; 17, 4345.
39. White SL. NagaiT, Akiyama SK, Reeves EJ, Grzegorzewski K, Olden K. Cancer Communications, 1991; 3, 83.
40. Dennis JW, Koch K, Beckner D. The Journal of the National Cancer Institute, 1989; 81, 1028.
41. Dennis JW. Cancer Research, 1986; 46, 5131.
42. Chao Li, Peipei Wang, Ziyang Fu, Yongtao Li, Shouju Li. Artificial Cells, Nanomedicine, and Biotechnology, 2019; 47, 2256.
43. Yagita M, Noda I, Maehara M, Fujieda S, Inoue Y, Hoshino T, Saksela E. The International Journal of Cancer, 1992; 52, 664.
44. Klein JLD, Roberts JD, George MD, Kurtzberg J, Breton P, Chermann JC, OldenK. British Journal of Cancer, 1999; 80, 87.
45. Skelton BW, White AH. Australian Journal of Chemistry, 1980; 33, 435.
46. Schneider MJ, Ungemach FS, Broquist HP, Harris TM. The Journal of the American Chemical Society, 1982; 104, 6863.
47. Kardono LBS, Kinghorn AD, Molyneux RJ. Phytochemical Analysis, 1991; 2, 120.
48. Schneider MJ, Ungemach FS, Broquist HP and Harris TM. Tetrahedron, 1983; 2, 29.
49. Gross PE, Baker MA, Carver JP, Dennis JW. Clinical Cancer Research,1995;1, 935.
50. Wikler DA, Holan G. The Journal of Medicinal Chemistry,1989;32, 2084.
51. Anzeveno PB, Creemer LJ, Daniel JK, King CH, Liu PS. The Journal of Organic Chemistry,1989;54, 2539.
52. Ahmed El Nemr. Tetrahedron, 56, 2000; 8579.
53. S. G. Pyne. Current Organic Synthesis, 2005; 2, 39-57.
54. Martίn R, Murruzzu C, Pericás MA, Riera A. The Journal of Organic Chemistry,2005; 70, 2325.
55. Gao Y, Hanson RM, Klunder JM, Ko SY, Masamune H, Sharpless KB. The Journal of the American Chemical Society,1987; 109, 5765.
56. Katsuki T, Martίn VS. Organic Reactions,1996; 48, 1-299.
57. Bernet B, Vasella A. Tetrahedron Letters,1983; 24, 5491.
58. Li YL, Wu YL. Tetrahedron Letters,1995; 36, 3875.
59. Still WC, Gennari C. Tetrahedron Letters, 1983; 24, 4405.
60. Guo H., O’Doherty GA. Organic Letters, 2006; 8, 1609.
61. Li M, Scott JG, O’Doherty GA. Tetrahedron Letters, 2004; 45, 1005.
62. Ceccon J, Greene AE, Poisson JF. Organic Letters, 2006; 8, 4739.
63. Denmark SE, Dixon JA. The Journal of Organic Chemistry,1998; 63, 6178.
64. Shi GF, Li JQ, Jiang XP, Cheng Y. Tetrahedron, 2008; 64, 5005.
65. Buchanan JG, Jigajinni VB, Singh G, Wightman RH. J. Chem. Soc., Perkin Trans. 1, 1987; 2377.
66. Buchanan JG, Singh G, Wightman RH. J. Chem. Soc., Chem. Commun., 1984; 1299.
67. Jiang XP, Cheng Y, Shi GF, Kang ZM. The Journal of Organic Chemistry, 2007; 72, 2212.
68. Sharma PK, Shah RN, Carver JP. Organic Process Research and Development, 2008;12, 831.
69. Tian YS, Joo JE, Kong BS, Pham VT, Lee KY, Ham WH. The Journal of Organic Chemistry,2009; 74, 3962.
70. Pyun SJ, Lee KY, Oh CY, Ham WH. Heterocycles,2004;62, 333.
71. Wardrop DJ, Bowen EG. Organic Letters, 2011; 13, 2376.
72. Cohen N, Banner BL, Laurenzano AJ, Carozza L. In Organic Syntheses; Wiley and Sons: New York, 1990; Vol. IV, pp 432-435.
73. Dunigan J, Weigel, LO. The Journal of Organic Chemistry, 1991; 56, 6225.
74. Li QR, Dong GR, Park SJ, Hong YR, Kim IS, Jung YH. European Journal of Organic Chemistry,2013; 4427.
75. Marshall JA, Seletsky BM, Luke GP. The Journal of Organic Chemistry,1994; 59, 3413.
76. Martinez PG, Dessolin M, Guibé F, Albericio F.J. Chem. Soc. Perkin Trans. 1,1999; 2871.
77. Au CWG, Pyne SG. The Journal of Organic Chemistry,2006;71, 7097.
78. Singh P, Manna SK, Panda G. Tetrahedron, 2014; 70 1363.
79. Garner P, Park JM. The Journal of Organic Chemistry, 1988; 53, 2979.
80. Srivastava AK, Das SK, Panda G. Tetrahedron, 2009; 65, 5322.
81. Qian BC, Kamori A, Kinami K, Kato A, Li YX, Fleet GWJ, Yu CY. Organic and Biomolecular Chemistry, 2016; 14, 4488.
82. Wang WB, Huang MH, Li YX, Rui PX, Hu XG, Zhang W, Su JK, Zhang ZL, Zhu JS, Xu WH, Xie XQ, Jia YM, Yu CY. Synlett, 2010; 488.
83. Tamura O, Toyao A, Ishibashi H. Synlett., 2002; 1344.
84. Nicolaou KC, Seitz SP, Pavia MR, Petasis NA. The Journal of Organic Chemistry, 1979; 44, 4011.
85. Masamune S, Lu LDL, Jackson WP, Kaiho T, Toyoda T. J. Am. Chem. Soc., 1982; 104, 5523.